Psychedelic Vantage
Psychedelic Vantage
  • Видео 58
  • Просмотров 37 366
Wake-Up Call | MAPS/Lykos Therapeutics | MDMA-AT
Disclaimer: The content presented on this RUclips channel is for informational and entertainment purposes only. The opinions expressed are solely those of the content creators and should not be construed as financial, investment, or professional advice. Viewers are advised to conduct their own research, consider their individual financial circumstances, and consult with a qualified professional before making any investment decisions.
Link to article by Shayla Love: www.wired.com/story/psychedelics-study-design-research-rcts/
Link to the full FDA hearing: ruclips.net/user/liveJqQKP8gcY1E
Просмотров: 284

Видео

Terran Biosciences' Transformative Therapeutics | An Interview with Founder and CEO, Dr. Sam Clark
Просмотров 18321 час назад
Disclaimer: The content presented on this RUclips channel is for informational and entertainment purposes only. The opinions expressed are solely those of the content creators and should not be construed as financial, investment, or professional advice. Viewers are advised to conduct their own research, consider their individual financial circumstances, and consult with a qualified professional...
Healing Veterans with Psychedelics | An Interview with Matthew ("Whiz") Buckley | No Fallen Heroes
Просмотров 160День назад
Disclaimer: The content presented on this RUclips channel is for informational and entertainment purposes only. The opinions expressed are solely those of the content creators and should not be construed as financial, investment, or professional advice. Viewers are advised to conduct their own research, consider their individual financial circumstances, and consult with a qualified professional...
Skipping the Trip | Abbvie x Gilgamesh Pharmaceuticals: The Epic of Gilgamesh Continued
Просмотров 17514 дней назад
Disclaimer: The content presented on this RUclips channel is for informational and entertainment purposes only. The opinions expressed are solely those of the content creators and should not be construed as financial, investment, or professional advice. Viewers are advised to conduct their own research, consider their individual financial circumstances, and consult with a qualified professional...
Psilocybin Trip Report: Life-Changing Mushroom Experience
Просмотров 372Месяц назад
Submit your own psychedelic experience. We can add visuals to all stories that are submitted in text form - PsychedelicVantage@gmail.com Credits: Video: Instagram - @Brucemichaelphoto Story by Frank Simanton A very special thanks to both Bruce and Frank for sharing this with Psychedelic Vantage. #tripreport #trip #psychedelicexperience #shrooms #Psilocybin
Investing Across the Psychedelic Medicine Ecosystem: An Interview with Cody Shandraw
Просмотров 497Месяц назад
#psychedelicresearch #psychedelicinvesting #biotechinvesting #biotechstocks #ketaminetherapy #healingREIT Disclaimer: The content presented on this RUclips channel is for informational and entertainment purposes only. The opinions expressed are solely those of the content creators and should not be construed as financial, investment, or professional advice. Viewers are advised to conduct their ...
DMT Trip Report: The Green Woman
Просмотров 3,1 тыс.Месяц назад
This video provides a graphic representation of a DMT trip report. #psychedelic #trip #psychedelics #dmt #tripreport #trip #report #psychedelicexperience
The Big Picture with Psychedelic Medicine: An Interview with Christian Angermayer
Просмотров 627Месяц назад
#christianangermayer #atailifesciences #atai #psychedelicresearch #biotech
5-MeO-DMT Trip Report: Letting Go
Просмотров 4802 месяца назад
This video provides a graphic representation of a DMT trip report. #psychedelic #trip #psychedelics #dmt #tripreport #5meodmt #5meo #psychedelicexperience
Psychedelic Biotech Stock Portfolio Updates
Просмотров 5252 месяца назад
#cybin #cmps #psychedelicinvest #biotechinvesting Disclaimer: The content presented on this RUclips channel is for informational and entertainment purposes only. The opinions expressed are solely those of the content creators and should not be construed as financial, investment, or professional advice. Viewers are advised to conduct their own research, consider their individual financial circum...
Psilocybin Trip Report: It's Okay to Cry
Просмотров 4662 месяца назад
This video provides a graphic representation of a Psilocybin trip report featuring a mushroom goddess #psychedelic #trip #psychedelics #mushroom #tripreport #shrooms #mushrooms #love The disclaimer in video says DMT, this video is in-fact a Psilocybin experience, my mistake Disclaimer: FLASH WARNING This trip report provides a personal account of a psychedelic experience and is being provided w...
Cybin’s Psilocybin Breakthrough | An Interview with CEO Doug Drysdale | $CYBN
Просмотров 1,5 тыс.2 месяца назад
#psychedelicresearch #biotech #cybin #psychedelics #psilocybin
Mindmed $MNMD | LSD’s Future in Psychiatry
Просмотров 4462 месяца назад
#mindmed #lsd #psychedelics #shroomstocks #psychedelicinvest Disclaimer: The content presented on this RUclips channel is for informational and entertainment purposes only. The opinions expressed are solely those of the content creators and should not be construed as financial, investment, or professional advice. Viewers are advised to conduct their own research, consider their individual finan...
DMT Trip Report: Am I Dead?
Просмотров 1,2 тыс.2 месяца назад
This video provides a graphic representation of a DMT trip report. #psychedelic #trip #psychedelics #dmt #tripreport Disclaimer: This trip report provides a personal account of a psychedelic experience and is being provided with expressed permission. Individual responses to psychedelics vary, and readers are urged to exercise caution, considering their health, mental state, and legal regulation...
$MNMD MindMed's Impressive 12-Week Data and Breakthrough Therapy Designation for LSD
Просмотров 3912 месяца назад
$MNMD MindMed's Impressive 12-Week Data and Breakthrough Therapy Designation for LSD
DMT Trip Report: Overcoming Heartbreak
Просмотров 4,3 тыс.3 месяца назад
DMT Trip Report: Overcoming Heartbreak
PSYLO's Next Generation Psychedelic Pipeline: An Interview with CSO and Co-Founder Sam Banister
Просмотров 3123 месяца назад
PSYLO's Next Generation Psychedelic Pipeline: An Interview with CSO and Co-Founder Sam Banister
DMT Trip Report: I Broke Through..
Просмотров 5703 месяца назад
DMT Trip Report: I Broke Through..
What's Going on with Cybin $CYBN?
Просмотров 9333 месяца назад
What's Going on with Cybin $CYBN?
Ibogaine's Future in Neuropsychiatry: Treating Addiction and Healing Brain Trauma | Dr. Deborah Mash
Просмотров 4874 месяца назад
Ibogaine's Future in Neuropsychiatry: Treating Addiction and Healing Brain Trauma | Dr. Deborah Mash
Power Moves | atai Life Sciences x Beckley Psytech | $ATAI
Просмотров 8695 месяцев назад
Power Moves | atai Life Sciences x Beckley Psytech | $ATAI
Analyzing the Psychedelic Biotech Sector with The Chart Guys | $ATAI , $MNMD , $CYBN , $GHRS , $CMPS
Просмотров 7725 месяцев назад
Analyzing the Psychedelic Biotech Sector with The Chart Guys | $ATAI , $MNMD , $CYBN , $GHRS , $CMPS
Groundbreaking Results from Mindmed $MNMD and Cybin $CYBN | Psychedelic Vantage
Просмотров 1,6 тыс.5 месяцев назад
Groundbreaking Results from Mindmed $MNMD and Cybin $CYBN | Psychedelic Vantage
The Future Role of Psychedelics in Addiction Recovery | Psychedelic Vantage
Просмотров 4255 месяцев назад
The Future Role of Psychedelics in Addiction Recovery | Psychedelic Vantage
Jake's Current Psychedelic Medicine Stock Portfolio | Psychedelic Vantage
Просмотров 7616 месяцев назад
Jake's Current Psychedelic Medicine Stock Portfolio | Psychedelic Vantage
Comprehensive Analysis of Compass Pathways: $CMPS | Psychedelic Vantage
Просмотров 7126 месяцев назад
Comprehensive Analysis of Compass Pathways: $CMPS | Psychedelic Vantage
Doug Drysdale, CEO of Cybin, Breaks Down Cybin’s Phase 1/2a Interim Data Using Intramuscular N,N-DMT
Просмотров 7996 месяцев назад
Doug Drysdale, CEO of Cybin, Breaks Down Cybin’s Phase 1/2a Interim Data Using Intramuscular N,N-DMT
Long vs. Short vs. Non-Hallucinogenic Psychedelics | Psychedelic Vantage Podcast
Просмотров 1397 месяцев назад
Long vs. Short vs. Non-Hallucinogenic Psychedelics | Psychedelic Vantage Podcast
DMT and Depression: A Conversation with Neuroscientist Dr. Elemer Piros - Part 2
Просмотров 2388 месяцев назад
DMT and Depression: A Conversation with Neuroscientist Dr. Elemer Piros - Part 2
DMT and Depression: A Conversation with Neuroscientist Dr. Elemer Piros - Part 1
Просмотров 3698 месяцев назад
DMT and Depression: A Conversation with Neuroscientist Dr. Elemer Piros - Part 1

Комментарии

  • @CM-io9zk
    @CM-io9zk День назад

    for me dont was a sad day at all ... lykos make some mistake on that trial and remember they start the phase 3 trial after that fda in 2023 approve the guidance for the psychedelic therapy.... i am confident that company with more money, more knowhow and that start the trial of phase 3 after the fda guideline will make the trial right ( compass, mindmen, cyben )... these pull back will aloud us to buy the dip....

  • @darialastochka7883
    @darialastochka7883 9 дней назад

    🙌🙌🙌

  • @darialastochka7883
    @darialastochka7883 14 дней назад

    Great video

  • @prtauvers
    @prtauvers 18 дней назад

    How is this different than an NDE? Same experience, no?

  • @geraintrickards8966
    @geraintrickards8966 27 дней назад

    This is very similar to my experience on changa

  • @DreamingJaguars
    @DreamingJaguars 28 дней назад

    I have met the blue lady many many times she is all powerful and wears many hats🧞‍♂️

  • @darialastochka7883
    @darialastochka7883 Месяц назад

    it is good he has such a good supportive dad

  • @c0nsci0usness
    @c0nsci0usness Месяц назад

    Love you cosmic brother. Beautiful story!

  • @Nitrogenius123
    @Nitrogenius123 Месяц назад

    great report, thanks for sharing so openly and interesting

  • @TheNatesway
    @TheNatesway Месяц назад

    No love for mindmed?

  • @darialastochka7883
    @darialastochka7883 Месяц назад

    🤌

  • @cartervermont8461
    @cartervermont8461 Месяц назад

    Excellent episode. Thank you guys both so much. Learned a lot. Appreciate the nuance especially. There’s space for everybody in this ecosystem. Love what you’re both doing. Thank you.

  • @joshuakelly997
    @joshuakelly997 Месяц назад

    I am In Construction and real estate. Is there a way to get into contact. As far as clinic renovations and requirements for storage In these facilities.

    • @PsychedelicVantage
      @PsychedelicVantage Месяц назад

      You can contact the team through this website under "Contact" section: healingrt.com/contact/

  • @christopherleubner6633
    @christopherleubner6633 Месяц назад

    You met the Green Tara. ❤

  • @jinto540
    @jinto540 Месяц назад

    Why cuttlefish?? Lol

  • @mfng3839
    @mfng3839 Месяц назад

    I met a redhead lady over a decade ago. This brought me back there. Thank you.

  • @sillybirdy1994
    @sillybirdy1994 Месяц назад

    This was absolutely beautiful. I have never done DMT but I did induce a lucid dream many years ago and believe I saw possibly the same green woman. She had rainbow hair and was happy to see me. I think I remember her greeting me like an old friend. She showed me many things, but when it was time for me to wake up she said she had to go, and seemed sad. I remember the feeling like it would be awhile before I could see her again. I haven't seen her again yet, and haven't tried to lucid dream again since. But I can tell you from first hand experience that magic is very real. Outside of the lucid dreaming DMT world, there are many forces and deitys with immesaurable power that you can interact with without drugs or sleep. All you have to do is tune in, and show respect and love. Just make sure to do your research before you try something. Thank you for making this. Good luck!!

  • @mattvieyra9475
    @mattvieyra9475 Месяц назад

    I have a woman call to me, insuring me the rabbit hole goes much deeper. Very motherly, i knew i could trust her. Helped me push to a blast off dose

  • @Nazzul
    @Nazzul Месяц назад

    Mine was a blue woman. She wanted to teach me about the DMT realm, but I spent all my time debating her nature and what she was.

    • @southlondon86
      @southlondon86 Месяц назад

      What did she say she was, sir?

    • @Nazzul
      @Nazzul Месяц назад

      @@southlondon86 It was tough to get an an entire clear conversation due to how chaotic my first trip was, but I was told this. She was a teacher/guide and she was a part of everyone.

    • @echo036
      @echo036 22 дня назад

      I saw the blue mother spirit during my first mushroom trip, she guided me through the whole way, teaching me about the experience and the integration process.

    • @paulinaacero420
      @paulinaacero420 19 дней назад

      Me too!!!! She was so loving and forgiving. She danced for me with her friends. They were like water with a glow. So beautiful! As if they were made of water ❤

  • @ApurvaOfficial
    @ApurvaOfficial Месяц назад

    Thanks for doing this guys, cheers!

  • @kelseypayne4863
    @kelseypayne4863 Месяц назад

    Great video! I love the trust the process motto and personal insights shared from the trip.

  • @olliestephens558
    @olliestephens558 Месяц назад

    This is the most comprehensive summary of the industry I've seen. Very excited for the future of psychedelics and how I can contribute to it

  • @darialastochka7883
    @darialastochka7883 Месяц назад

    🤌

  • @kelseypayne4863
    @kelseypayne4863 Месяц назад

    Amazing interview! I love the passion Christian has for psychedelics, it is indeed palpable

  • @KMS7588
    @KMS7588 Месяц назад

    Incredible company. Incredible founder.

  • @joshuakelly997
    @joshuakelly997 Месяц назад

    thank you for interview, really appreciate to see the humble CEO with great understanding of psychedelics.

  • @KolomerEntertainment
    @KolomerEntertainment 2 месяца назад

    🔥🔥🔥

  • @darialastochka7883
    @darialastochka7883 2 месяца назад

    🙏

  • @RR-dj2pk
    @RR-dj2pk 2 месяца назад

    Thank you guys for bringing us all this helpful data

  • @blaizekoon8557
    @blaizekoon8557 2 месяца назад

    When cybin goes commercial... 🚀 I'll be patient and keep adding to my position.

  • @ideology_superstore
    @ideology_superstore 2 месяца назад

    You guys got any eyes on GH Research?

    • @PsychedelicVantage
      @PsychedelicVantage 2 месяца назад

      We keep a very close eye on GH Research. We are curious to see if their broad method of use patents with 5-MeO-DMT end up being granted in the US. -Jake

  • @matthijsbos4870
    @matthijsbos4870 2 месяца назад

    Cybin has a massive float/OS. That stock has been diluted and diluted and diluted. I find it very funny how the CEO is being praised by retail, while he has run the ATM at 0,6, pushing the stock back to 0,28. Any other stock, retail would be furious. CEO created a 769m OS situation, the largest float/OS in the sector. The latest offering, a blatant lie about a premium and a massive blow to retail (again), sold as 'at premium'. 150m seems like a lot, but it is not at all with that many trials. If that CEO had ANY respect for retail he would have sought a strong partner for funding. Like any other normal pre-clinical Bio does.

  • @MishaLan23
    @MishaLan23 2 месяца назад

    I don’t understand the CYBN RS logic. You say for institutional investment but after this latest private placement more than half of their shares are owned by institutional investors. Even if the RS were coming, if it wasn’t a bullish move, why would all these savvy biotech investors be piling in right now?

    • @PsychedelicVantage
      @PsychedelicVantage 2 месяца назад

      Fair point. I did say that institutions are already interested but I should have been more clear with my view that for the FUTURE, they may need to R/S to continue bringing on institutional investors as they raise more money in the future. Also you make another fair point about the institutions piling in now. Surely they considered these risks. Speculation here: Perhaps they feel that the share price can increase from here despite a potential R/S in the future. Perhaps many are longer term holders of the stock as well and see the potential R/S as not being significant in the grand scheme of things. -Jake

    • @MishaLan23
      @MishaLan23 2 месяца назад

      @@PsychedelicVantage yeah that last part is how I view an RS now after the data and their recent investors. Even if it happens, their current market cap is small compared to what I think it could be that an RS doesn’t scare me. I also think their results/IP makes them a prime target for acquisition and now with BTD derisking them from a regulatory standpoint, this becomes a real possibility before commercialize.

    • @PsychedelicVantage
      @PsychedelicVantage 2 месяца назад

      I absolutely agree with you. -Jake

  • @simonposener7601
    @simonposener7601 2 месяца назад

    I have been watching CMPS and hold stock at 8.6 per share... You have certainly intrigued me about CYBN... It certainly has potential... My brother is the chief medical officer for Journey Collab... .. interesting space... Journey is evaluating the treatment of AUD... Alcohol Abuse disorder.. it is not public at this time... Hopefully the CMPS Phase 3 lifts the CYBN boat.. what are your thoughts or prognosis on CYBN and CMPS? How do you think the Phase 3 results will be and will it get approval etc.. ??

    • @PsychedelicVantage
      @PsychedelicVantage 2 месяца назад

      Journey Collab is an interesting company. I believe they are backed by Sam Altman as well. Lots of sleeping giants that are private right now. In terms of comparing CMPS and CYBN, it's tough to say. CMPS is looking at TRD while CYBN is looking at second line MDD (Larger TAM but also faces competition from more drugs). Most analysts have given a 75% POS (probability of success) for Compass's phase 3 COMP005 trial. I think CMPS will see good results but I do have concerns about trial participants coming off of background medication in this trial. I don't think it is ideal to go into a high dose psilocybin experience if you might be dealing with SSRI/SNRI withdrawals. I hope that there aren't to many serious adverse events in this trial, but if there was, it wouldn't surprise me either. Overall I think COMP005 will be a success and COMP006, looking at 2 doses three weeks apart before the primary endpoint at 6 weeks, will also show good results. I think that ultimately, COMP360 gets approval. I like Compass a lot but I like CYBN much more. I can't think of another company in the space which has TWO DIFFERENT late stage drug candidates at the current moment. I believe CYBN is much more undervalued than CMPS is right now (also undervalued). These are all just my opinions of course. Thank you for watching and for the questions! -Jake

    • @simonposener7601
      @simonposener7601 2 месяца назад

      Thank you for those details... I will look more and certainly keep in touch with your videos.. not sure who Sam Altman is?.. @@PsychedelicVantage

    • @simonposener7601
      @simonposener7601 2 месяца назад

      Thanks jake. It's a good reason for me to give my brother a call, get caught up and see how his perspectives have changed in recent days. It's been a couple months since I've chatted. Have a great day.

    • @angelocuseo
      @angelocuseo 2 месяца назад

      I wasn't aware that Cybin was requiring participants to come of SSRIs during their phase III trials. Was that discussed in your recent interview with Doug Drysdale? Do you know where one can find additional information about Phase III trial details? @@PsychedelicVantage

    • @jake3028
      @jake3028 2 месяца назад

      The exact opposite. They are having trial participants stay on background medication. You can find info here: s28.q4cdn.com/259445127/files/CYBN-CYB003-Program-Update-March-13-2024-Final.pdf

  • @darialastochka7883
    @darialastochka7883 2 месяца назад

    Yin Yang

  • @nickd118
    @nickd118 2 месяца назад

    Jake still not down with MindMed damn dude, =( The CYBN reverse split is why Im not invested in them yet. I can go through that again with another Psychedelic's company.

    • @PsychedelicVantage
      @PsychedelicVantage 2 месяца назад

      I don't dislike MNMD. I just like ATAI and CYBN more personally, and I prefer to make very concentrated bets in this space. -Jake

    • @nickd118
      @nickd118 2 месяца назад

      @@PsychedelicVantage fair enough. I only hold Mindmed/Atai and Numinous from the very beginning. I did own Cybin very early on and sold. I will definitely get in after the reverse split and when the price fizzes out.

  • @jthomaslo87
    @jthomaslo87 2 месяца назад

    After reading books and doing research, I got a credit card and went to "Nihue Rao" in Peru. It was co-owned by Dr. Joe Tafur. They pick you from the airport. My ayahuasca (dmt) retreat was so amazing i went back 2 more times. There is a documentary about this special place on RUclips called "the song that calls to home" I had a divine intervention that changed my life. I was so broken. It made me better. ❤

  • @a7699aaa
    @a7699aaa 2 месяца назад

    When is your next interview with Robert Barrow? I want to see you interviewing Barrow so bad!

  • @kev5162
    @kev5162 2 месяца назад

    How soon could cyb003 go to market? Isn’t that what is gonna get this thing rolling for investors??

    • @PsychedelicVantage
      @PsychedelicVantage 2 месяца назад

      It's hard to give an exact timeline, but considering CMPS says that they are looking at 2027 for commercialization (if approved), my guess is it would be 2028 for CYBN (if approved). This is just a guess though from me. In terms of what gets things rolling for investors: I would say before commercialization, the data from late stage trials is what will get people interested and has already in Cybin's recent smaller trial (150 million dollars raised from top healthcare investors). Data readouts can be looked at as value inflection points for investors. Phase 2a results for example from Cybin's DMT study (anticipated by end of year) can be looked at as an inflection point (hopefully we get rate cuts so news is received more positively by market). While yes, the biggest goal is of course going to market, investors can get interested before that happens. There are plenty of pre-revenue biotech companies right now that are worth billions. I appreciate the question and thank you for watching! -Jake

  • @localfocalkc
    @localfocalkc 2 месяца назад

    I'm very happy for the patients.

  • @Workn3t
    @Workn3t 2 месяца назад

    Adam why do you seem annoyed 😂

    • @PsychedelicVantage
      @PsychedelicVantage 2 месяца назад

      I have no clue, but this isn't the first time I've heard this. Lol 😭😭

  • @DICHI441
    @DICHI441 2 месяца назад

    its nice to see new psychedelic channels popping up, its good inspiration snd competition for my own channel and work, hope to see more of you😁

  • @johnracine4853
    @johnracine4853 2 месяца назад

    Thank you for the candor in the trip reports. It’s so beautiful to have a forum where honesty and vulnerability equals healing.

  • @darialastochka7883
    @darialastochka7883 2 месяца назад

    Hashtag #normalizecrying

  • @SleepingDragon1
    @SleepingDragon1 2 месяца назад

    I was addicted to benzos for 5-6 years and although I've been benzo free for 4 years I still haven't fully recovered. Do you think Etifoxine could help me or make things worse for me?

    • @PsychedelicVantage
      @PsychedelicVantage 2 месяца назад

      I wouldn't recommend etifoxine for anything. I have had better luck using ashwagandha (Sensoril or Shoden) when trying to manage anxiety.

  • @a7699aaa
    @a7699aaa 2 месяца назад

    When the next interview with Robert?

  • @MishaLan23
    @MishaLan23 2 месяца назад

    Great idea to start doing trip reports. These were what got me into psych investing. I’ve generally become less anxious around existential issues after listening to hundreds of these and been convinced there is something to them

  • @a7699aaa
    @a7699aaa 2 месяца назад

    Do you regret not investing in MindMed when prices were this low?

    • @PsychedelicVantage
      @PsychedelicVantage 2 месяца назад

      Personally I do not regret it. Obviously it would have been great to have these gains now. Ultimately, I am happy with my portfolio. Definitely a valid question for you to ask though. -Jake

  • @user-kf8rm4mc8y
    @user-kf8rm4mc8y 2 месяца назад

    amazing amazing!

  • @trevornewton9687
    @trevornewton9687 2 месяца назад

    That’s actually insane